CRP and rheumatoid arthritis: In patients with early active RA who had received little or no prior MTX, abatacept plus MTX has been shown to be superior to MTX alone in achieving remission (DAS28 (CRP) < 2.6) and in maintenance of remission and structural benefits 6 months following withdrawal of all RA medication [16, 23].